Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma.

Published: 15-06-2020| Version 2 | DOI: 10.17632/kc7wmn3rcs.2
Contributor:
Juha Rantala

Description

Supplementary data files for Mäkelä et al. Supplementary data 1. Ex vivo drug screening results. Supplementary data 2. NGS profiling results for MISB18 urachal cancer cell line.

Files